Zhong Lan Wei
Direktor/Vorstandsmitglied bei ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.
Profil
Zhong Lan Wei currently works at Zhejiang Garden Biopharmaceutical Co., Ltd., as Vice Chairman from 2022 and Zhejiang Garden Pharmaceutical Co., Ltd., as Executive Director from 2021.
Aktive Positionen von Zhong Lan Wei
| Unternehmen | Position | Beginn |
|---|---|---|
| ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD. | Direktor/Vorstandsmitglied | 19.04.2022 |
Zhejiang Garden Pharmaceutical Co., Ltd.
 Zhejiang Garden Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Garden Pharmaceutical Co., Ltd. is engaged in manufacture pharmaceutical products including Xinnaojian tablets, panaxnotoginseng capsules, sucralfate tablets and Lansoprazole.The company leading product is Xinnaojian traditional chinese tablet, it can be used in the therapy of cardiovascular and cerebrovascular diseases (high blood pressure, hyperlipemia) and cytopenia caused by the teletherapy and chemotherapy of tumor. The company was founded in August, 2001 and is headquartered in Dongyang China. | Direktor/Vorstandsmitglied | 29.09.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Zhejiang Garden Pharmaceutical Co., Ltd.
Zhejiang Garden Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Garden Pharmaceutical Co., Ltd. is engaged in manufacture pharmaceutical products including Xinnaojian tablets, panaxnotoginseng capsules, sucralfate tablets and Lansoprazole.The company leading product is Xinnaojian traditional chinese tablet, it can be used in the therapy of cardiovascular and cerebrovascular diseases (high blood pressure, hyperlipemia) and cytopenia caused by the teletherapy and chemotherapy of tumor. The company was founded in August, 2001 and is headquartered in Dongyang China. | Health Technology |
